Clinical characteristics of Japanese children with optic neuritis

Pediatric Neurology

Volumn 31, Issue 1, 2004, Pages 42-45

  Mizota, Atsushi ^a,b   Niimura, Miyoko ^a   Adachi Usami, Emiko ^a  

^a CHIBA UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADOLESCENT; ANAMNESIS; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; ENCEPHALOMYELITIS; EUROPE; FEMALE; HEMISPHERIC DOMINANCE; HUMAN; IMMUNIZATION; INFECTION; JAPAN; MALE; MEDICAL RECORD; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NORTH AMERICA; ONSET AGE; OPTIC NERVE DISEASE; PRIORITY JOURNAL; SYSTEMIC DISEASE; VISUAL ACUITY;

ADOLESCENT; ADRENAL CORTEX HORMONES; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; FEMALE; FUNCTIONAL LATERALITY; HUMANS; INFANT; JAPAN; MALE; MULTIPLE SCLEROSIS; OPTIC NEURITIS; PAPILLEDEMA; RECOVERY OF FUNCTION; RECURRENCE; VISUAL ACUITY;

EID: 3142562509     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2003.11.011     Document Type: Article

References (20)

1. Optic Neuritis Study Group. The clinical profile of optic neuritis experience of the optic neuritis treatment trial. Arch Ophthalmol. 109:1991;1673-1678
2. Beck R.W., Cleary P.A., Trobe J.D., et al. Optic Neuritis Study Group The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med. 329:1993;1764-1769
3. Optic Neuritis Study Group. The 5-year risk of MS after optic neuritis Experience of the Optic Neuritis Treatment Trial. Neurology. 49:1997;1404-1413
4. Kennedy C., Carroll F.D. Optic neuritis in children. Tr Am Acad Ophth Otol. 64:1960;700-712
5. Meadows S.P. Doyne memorial lecture (1969). Retrobulbar and optic neuritis in childhood and adolescence. Tr Ophthalmol Soc UK. 89:1970;603-638
6. Kriss A., Francis D.A., Cuendet F., et al. Recovery after optic neuritis in childhood. J Neurol Neurosurg Psychiat. 51:1988;1253-1258
7. Riikonen R., Donner M., Erkkilä H. Optic neuritis in children and its relationship to multiple sclerosis A clinical study of 21 children. Dev Med Child Neurol. 30:1988;349-359
8. Visudhiphan P., Chiemchanya S., Santadusit S. Optic neuritis in children Recurrence and subsequent development of multiple sclerosis. Pediatr Neurol. 13:1995;293-295
9. Lucchinetti C.F., Kiers L., O'Duffy A., et al. Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology. 49:1997;1413-1418
10. Brady K.M., Brar A.S., Lee A.G., Coats D.K., Paysse E.A., Steinkuller P.G. Optic neuritis in children Clinical features and visual outcome. JAAPOS. 3:1999;98-103
11. Morales D.S., Siatkowski R.M., Howard C.W., Warmen R. Optic neuritis in children. J Pediatr Ophthalmol Strabismus. 37:2000;254-259
12. Hwang J.M., Lee Y.J., Kim M.K. Optic neuritis in Asian children. J Pediatr Ophthalmol Strabismus. 39:2002;26-32
13. Kuroiwa Y., Igata A., Itahara K., et al. National survey of multiple sclerosis in Japan. Neurology. 25:1975;845-851
14. Corona-Vazquez T., Ruiz-Sandoval J., Arriada-Mendicoa N. Optic neuritis progressing to multiple sclerosis. Acta Neurol Scand. 95:1997;85-89
15. Isayama Y., Takahashi T., Shimoyoma T., Yamadori A. Acute optic neuritis and multiple sclerosis. Neurology. 32:1982;73-76
16. Hader W.J., Elliot M., Ebers G.C. Epidemiology of multiple sclerosis in London and Middlesex country, Ontario, Canada. Neurology. 38:1988;617-621
17. Suehiro S., Adachi-Usami E., Miyauchi O., et al. Clinical profiles of patients with optic neuritis at the ophthalmological department of Chiba University. Neuro-Ophthalmology. 27:2002;153-162
18. Rizzo J.F., Lessel S. Risk of developing multiple sclerosis after uncomplicated optic neuritis A long term prospective study. Neurology. 38:1988;185-190
19. Sandberg-Wollheim M., Bynke H., Cronqvist S., Holås S., Platz P., Ryder L.P. A long-term prospective study of optic neuritis Evaluation of risk factors. Ann Neurol. 27:1991;386-393
20. Ozakbas S., Idiman E., Baklan B., Yulug B. Childhood and juvenile onset multiple sclerosis Clinical and paraclinical features. Brain Dev. 25:2003;233-236